Missing out on IPO gains, AstraZeneca's falling share price, growing demand to be a Cake Box franchisee and green investing with TRIG
In this week’s podcast: how retail investors often miss out on big first day gains with IPOs. Find out what investors think about AstraZeneca’s vaccine roll-out being halted in parts of the world and why its shares were falling months before this incident. Dan Coatsworth examines Greggs’ latest results and chats with…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from AJ Bell Money & Markets
See all episodes →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.